Latest Royalties News

Pilot Energy has locked in a $1.8 million convertible note funding deal led by Discovery Investments, fueling its transition from oil production to carbon storage at the Cliff Head site. The funding hinges on upcoming shareholder approval and replaces a previously stalled arrangement.

Manhattan Corporation has secured a binding agreement to acquire the Hook Lake Project in Nunavut, Canada, featuring a high-grade gold deposit and polymetallic prospects. The company aims to validate historical estimates and advance exploration with a seasoned team onboard.

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

Legacy Minerals has resumed drilling at its expansive Thomson Project in NSW, focusing on the promising Cut-B anomaly after completing work on the F4 anomaly. Early results and historical data suggest a significant intrusion-related gold-copper system with high-grade mineralisation potential.

Sabre Resources has completed the sale of its Ninghan Gold Project to Capricorn Metals, receiving $1.85 million in initial consideration plus ongoing royalties and milestone payments.

Catalyst Metals has secured the Old Highway Gold Project from Sandfire Resources for A$32.5 million, aiming to boost production with a satellite mine feeding its Plutonic processing plant. The project promises a 4-year mine life producing 35,000 ounces annually at competitive costs.

Adelong Gold has locked in a binding agreement to acquire the Lauriston Gold Project, boasting exceptional high-grade gold mineralisation adjacent to the world-class Fosterville Mine. The acquisition, backed by a $3 million capital raise, positions Adelong to rapidly expand its Victorian gold portfolio.

Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.

Guzman y Gomez has unveiled an ambitious expansion and margin improvement plan at the 2025 Macquarie Australia Conference, reaffirming its FY25 guidance and spotlighting strong franchise growth and operational excellence.

LCL Resources has renegotiated its sale option agreement with Tiger Gold Corp, increasing the total consideration to $14 million and removing the 'Stay Private' clause. The revised terms will be presented for shareholder approval at the upcoming AGM.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.